Raymond Yau, MD
Interventional Cardiology · Albuquerque, NMNPI 1497932503
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Abiomed at 54.5% of the total. Among interventional cardiology clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,017 payments — averaging $168.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$93K
- Livanova USA, Inc.$41K
- Abbott$22K
- Boston Scientific$5K
- Asahi Intecc USA, Inc.$3K
- Philips North America LLC$2K
- plus $5K from 29 others
Across 34 payments — averaging $1294.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$44K
- Abiomed$408
What the payments were for
- Consulting fees$32,55019%
- Speaking & faculty fees$72,17342%
- Travel & lodging$28,41017%
- Food & beverage$37,80122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 349 | $93,200 |
| Livanova USA, Inc. | 61 | $40,773 |
| Abbott | 153 | $21,669 |
| Boston Scientific | 138 | $4,995 |
| Asahi Intecc USA, Inc. | 34 | $3,320 |
| Philips North America LLC | 52 | $1,914 |
| Shockwave Medical, Inc | 53 | $965 |
| Cardiovascular Systems Inc. | 22 | $628 |
| Medtronic(2 entities) | 19 | $584 |
| Amgen | 34 | $521 |
| Johnson & Johnson | 16 | $308 |
| Novartis | 12 | $274 |
| AstraZeneca | 17 | $271 |
| E.r. Squibb & Sons, L.L.C. | 14 | $252 |
| Cvrx, Inc. | 3 | $247 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $209 |
| Chiesi USA, Inc. | 2 | $139 |
| AbbVie | 1 | $135 |
| Portola Pharmaceuticals, LLC | 1 | $132 |
| Pfizer | 4 | $74 |
| Edwards Lifesciences | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Merck | 2 | $28 |
| EKOS Corporation | 1 | $26 |
| Biosense Webster, Inc. | 2 | $24 |
| Cordis US CORP. | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Teleflex LLC | 1 | $21 |
| Terumo Medical Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Ancora Heart, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$60,395
- LifeSPARC$39,679
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$18,725
- ASAHI PTCA Guide Wire$1,799
- SYNERGY$563
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$370
- CROSSBOSS$284
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$278
- (5027) Intact Vascular Und$229
- Watchman$220
- STINGRAY$150
- ASAHI Corsair Pro XS Microcatheter$149
- CARDIOMEMS$140
- AVYCAZ$135
- ANDEXXA$132
- COROFLOW$129
- KENGREAL$124
- Xience Sierra Coronary Stent$120
- ROTABLATOR$118
- AVVIGO$118
How this compares
$170,933 in reported general payments places this provider in the 95th percentile of 25 interventional cardiology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 241 | $277,703 |
| JardianceEmpagliflozin | 303 | $256,344 |
| EntrestoSacubitril/Valsartan | 177 | $172,962 |
| XareltoRivaroxaban | 102 | $134,259 |
| Repatha SureclickEvolocumab | 98 | $70,001 |
| FarxigaDapagliflozin Propanediol | 47 | $48,439 |
| OzempicSemaglutide | 28 | $25,952 |
| Praluent PenAlirocumab | 20 | $13,964 |
| BrilintaTicagrelor | 17 | $11,946 |
| Repatha PushtronexEvolocumab | 19 | $11,265 |
| Atorvastatin Calcium | 619 | $10,283 |
| ClopidogrelClopidogrel Bisulfate | 567 | $9,025 |
| Metoprolol Succinate | 418 | $6,865 |
| Carvedilol | 487 | $5,117 |
| Rosuvastatin Calcium | 230 | $4,407 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $74 | $277,703241 claims |
| Boehringer IngelheimJardiance | $29 | $256,344303 claims |
| NovartisEntresto | $274 | $172,962177 claims |
| Johnson & JohnsonXarelto | $308 | $134,259102 claims |
| AstraZenecaFarxiga, Brilinta | $271 | $60,38564 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 25 interventional cardiology providers in New Mexico.
Other interventional cardiology in Albuquerque
- Mark BieniarzAlbuquerque$207K
- Robert FedericiAlbuquerque$77K
- Sharif HalimAlbuquerque$22K
- Geoffrey KunzAlbuquerque$22K
- Charles KimAlbuquerque$9K
- Harvey WhiteAlbuquerque$3K
- Guilherme MarinAlbuquerque$3K
- James BlankenshipAlbuquerque$2K
- John BattyAlbuquerque$82
- Abdul KhanLas Cruces$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.